Recent News

• 06.11.2025 - Lachlan Hanbury-Brown
• 06.11.2025 - Lachlan Hanbury-Brown
• 06.11.2025 - Thomas Shrader
• 06.11.2025 - Thomas Shrader
• 06.09.2025 - Harrow Acquires U.S. Commercial Rights to BYQLOVI™ (Clobetasol Propionate Ophthalmic Suspension) 0.05% from Formosa Pharmaceuticals
• 06.09.2025 - Harrow Acquires U.S. Commercial Rights to BYQLOVI™ (Clobetasol Propionate Ophthalmic Suspension) 0.05% from Formosa Pharmaceuticals
• 05.28.2025 - Craig-Hallum 22nd Annual Institutional Investor Conference
• 05.21.2025 - May 21, 2025 - May 22, 2025 : B. Riley Securities 25th Annual Investor Conference
• 05.14.2025 - Harrow to Present at Two Investor Conferences in May
• 05.14.2025 - Harrow to Present at Two Investor Conferences in May

Recent Filings

• 06.11.2025 - 4 Statement of changes in beneficial ownership of securities
• 06.09.2025 - 8-K Current report
• 06.05.2025 - 4 Statement of changes in beneficial ownership of securities
• 05.14.2025 - 4/A Statement of changes in beneficial ownership of securities
• 05.14.2025 - 4/A Statement of changes in beneficial ownership of securities
• 05.14.2025 - 4 Statement of changes in beneficial ownership of securities
• 05.08.2025 - 10-Q Quarterly report [Sections 13 or 15(d)]